Open AccessImpact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV
Author(s) -
Mohamed N'dongo Sangaré,
Jean-Guy Baril,
Alexandra de Pokomandy,
Claudie Laprise,
Catherine Deshaies,
Marina B. Klein,
Réjean Thomas,
Cécile Tremblay,
Michel Roger,
Costa Pexos,
Zoë R Greenwald,
Nimâ Machouf,
Madéleine Durand,
Isabelle Hardy,
Mamadou Dakouo,
Louise Laporte,
Helen Trottier
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000023335
Subject(s) - dolutegravir , medicine , hazard ratio , viral load , regimen , viremia , cohort , oncology , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , confidence interval